| Literature DB >> 35814309 |
Bahiru Tesfaye1, Temesgen Tilahun2, Worku Dechasa Heyi3, Rut Oljira3.
Abstract
Objectives: Screening for precancerous cervical lesions and providing access to effective treatment can significantly improve the likelihood of survival. To identify associated factors of positive visual inspection of the cervix with acetic acid test for precancerous cervical lesions among women screened for cervical cancer at public health facilities in Woliso Town, Southwest Shoa, Ethiopia.Entities:
Keywords: Precancerous; Southwest Shoa; VIA test; Woliso town; acetic acid; cervical lesions
Year: 2022 PMID: 35814309 PMCID: PMC9260562 DOI: 10.1177/20503121221108227
Source DB: PubMed Journal: SAGE Open Med ISSN: 2050-3121
Sociodemographic characteristics of study participants at public health facilities, Southwest Shoa, Ethiopia, 2018.
| Variable | Precancerous cervical lesions | |
|---|---|---|
| Case | Control | |
| Age in years | ||
| 30–34 | 35 (40.7) | 56 (32.6) |
| 35–39 | 30 (34.9) | 64 (37.2) |
| 40–44 | 4 (4.7) | 27 (15.7) |
| 45–49 | 17 (19.8) | 25 (14.5) |
| Marital status | ||
| Married | 68 (79.1) | 153 (89.0) |
| Divorced | 9 (10.5) | 11(6.4) |
| Widowed | 9 (10.5) | 8 (4.7) |
| Age at marriage | ||
| 10–14 | 9 (10.5) | 20 (11.6) |
| 15–19 | 61 (70.9) | 103 (59.9) |
| 20–24 | 14 (16.3) | 34 (19.8) |
| 25–29 | 2 (2.3) | 15 (8.7) |
| Educational status | ||
| Unable to read and write | 44 (51.2) | 79 (45.9) |
| Read and write | 7 (8.1) | 10 (5.8) |
| Elementary(1–8 grade) | 14 (16.3) | 41 (23.8) |
| Secondary and above (9–12 grade) | 9 (10.5) | 27 (15.7) |
| Certificate and above | 12 (14.0) | 15 (8.7) |
| Ethnicity | ||
| Oromo | 58 (67.4) | 110 (64.0) |
| Amhara | 14 (16.3) | 33 (19.2) |
| Tigrie | 2 (2.3) | 8 (4.7) |
| Gurageh | 12 (14.0) | 21 (12.2) |
| Average monthly income in USD | ||
| <66 | 74 (86.0%) | 143 (83.1%) |
| ⩾66 | 12 (14.0%) | 29 (16.9%) |
Reproductive health characteristics of study participants at health facilities, Southwest Shoa, Ethiopia, 2018.
| Variable | Precancerous cervical lesions | |
|---|---|---|
| Case | Control | |
| Ever used hormonal contraceptive methods | ||
| Yes | 67 (77.9) | 138 (80.2) |
| No | 19 (22.1) | 34 (19.8) |
| Age at menarche | ||
| <13 years | 12 (14) | 21 (12.2) |
| 13–15 years | 66 (76.7) | 123 (71.5) |
| 16–18 years | 8 (9.3) | 28 (16.3) |
| Parity(delivery experience) | ||
| 0 | 1 (1.2) | 9 (5.2) |
| 1–2 | 18 (20.9) | 37 (21.5) |
| 3–4 | 14 (16.3) | 53 (30.8) |
| ⩾5 | 53 (61.6) | 73 (42.4) |
| Age at first birth | ||
| <20 | 67 (78.8) | 94 (57.7) |
| ⩾20 | 18 (21.2) | 69 (42.3) |
| Ever experienced abortion | ||
| Yes | 57 (66.3) | 80 (46.5) |
| No | 29 (33.7) | 92 (53.5) |
| Family history of cervical cancer | ||
| Yes | 4 (4.7) | 6 (3.5) |
| No | 82 (95.3) | 166 (96.5) |
Lifestyle and sexual characteristics of study participants at health facilities, Southwest Shoa, Ethiopia, 2018.
| Variable | Precancerous cervical lesions | |
|---|---|---|
| Case | Control | |
| Ever Screened for cervical precancerous lesion | ||
| Yes | 0 (0) | 0 (0) |
| No | 86 (100) | 172 (100) |
| Ever smokes | ||
| Yes | 4 (4.7) | 2 (1.2) |
| No | 82 (95.3) | 170 (98.8) |
| Age at first sexual intercourse | ||
| <18 years | 60 (69.8) | 57 (33.1) |
| ⩾18 years | 26 (30.2) | 115 (66.9) |
| Condom use | ||
| Sometimes | 29 (33.7) | 119 (69.2) |
| Never | 57 (66.3) | 53 (30.8) |
| Ever had a history of pelvic infection | ||
| Yes | 27 (31.4) | 29 (16.9) |
| No | 59 (68.6) | 143 (83.1) |
| Ever had a history of STDs | ||
| Yes | 43 (50.0) | 28 (16.3) |
| No | 43 (50.0) | 144 (83.7) |
| Lifetime sexual partner | ||
| One | 8 (9.3) | 66 (38.4) |
| Two or more | 78 (90.7) | 106 (61.6) |
| HIV status | ||
| Positive | 27 (31.4) | 12 (7.0) |
| Negative | 59 (68.6) | 160 (93.0) |
Multivariate analysis of determents of positive VIA test at health facilities in Southwest Shoa, Ethiopia, 2018.
| Variables | Precancerous cervical lesions | COR (CI 95%) | AOR (95% CI) | ||
|---|---|---|---|---|---|
| Case | Control | ||||
| Age of participants | |||||
| 30–34 | 35 (40.7) | 56 (32.6) | 1.00 | 1.00 | |
| 35–39 | 30 (34.9) | 64 (37.2) | 1.33 (0.72–2.44) | 1.22 (0.61–2.42) | 0.352 |
| 40–44 | 4 (4.7) | 27 (15.7) | 4.21 (1.36–13.08) | 4.11 (1.20–14.05) | 0.013 |
| 45–49 | 17 (19.8) | 25 (14.5) | 0.91 (0.43–1.94) | 1.221 (0.44–3.34) | 0.825 |
| Parity (delivery experience) | |||||
| 0 | 1 (1.2) | 9 (5.2%) | 1.00 | 1.00 | |
| 1–2 | 18 (20.9) | 37 (21.5%) | 0.22 (0.027–1.94) | 6.31 (0.77–51.38) | 0.177 |
| 3–4 | 14 (16.3) | 53 (30.8) | 0.42 (0.49–3.60) | 1.61 (0.81–3.17) | 0.423 |
| ⩾5 | 53 (61.6) | 73 (42.4) | 0.15 (0.019–1.24) | 2.78 (1.39–5.56) | 0.011 |
| Age at first birth | |||||
| <20 years | 67 (78.8) | 94 (57.7) | 2.73 (1.49–5.009) | 5.45 (1.41–21.04) | 0.001 |
| ⩾20 years | 18 (21.2) | 69 (42.3) | 1.00 | 1.00 | |
| Age at first sexual intercourse | |||||
| <18 years | 60 (69.8) | 57 (33.1) | 4.65 (2.66–8.14) | 4.73 (1.79–12.48) | <0.001 |
| ⩾18 years | 26 (30.2) | 115 (66.9) | 1.00 | 1.00 | |
| Condom use | |||||
| Sometimes | 29 (33.7) | 119 (69.2) | 1.00 | 1.00 | |
| Never | 57 (66.3) | 53 (30.8) | 4.41 (2.54–7.66) | 11.06 (3.93–31.1) | <0.001 |
| History of STDs | |||||
| Yes | 43 (50.0) | 28 (16.3) | 5.14 (2.86–9.23) | 4.05 (2.15–7.76) | <0.001 |
| No | 43 (50.0) | 144 (83.7) | 1.00 | 1.00 | |
| Lifetime sexual partner | |||||
| One | 8 (9.3) | 66 (38.4) | 1.00 | 1.00 | |
| Two or more | 78 (90.7) | 106 (61.6) | 6.07 (2.75–13.37) | 4.81(1.37-16.90) | <0.001 |
| HIV status | |||||
| Positive | 27 (31.4) | 12 (7.0) | 6.10 (2.90–12.82) | 3.85(1.68-8.83) | <0.001 |
| Negative | 59 (68.6) | 160 (93.0) | 1.00 | ||
p < .05.